
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
China Jo-Jo Drugstores Inc (CJJD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/25/2025: CJJD (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -16.33% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 9.95M USD | Price to earnings Ratio - | 1Y Target Price 7 |
Price to earnings Ratio - | 1Y Target Price 7 | ||
Volume (30-day avg) 23644 | Beta -0.15 | 52 Weeks Range 1.29 - 3.39 | Updated Date 03/31/2025 |
52 Weeks Range 1.29 - 3.39 | Updated Date 03/31/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.31 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.8% | Operating Margin (TTM) -3.12% |
Management Effectiveness
Return on Assets (TTM) -3.98% | Return on Equity (TTM) -29.67% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 30313541 | Price to Sales(TTM) 0.07 |
Enterprise Value 30313541 | Price to Sales(TTM) 0.07 | ||
Enterprise Value to Revenue 0.21 | Enterprise Value to EBITDA 9.06 | Shares Outstanding 6178360 | Shares Floating 3905877 |
Shares Outstanding 6178360 | Shares Floating 3905877 | ||
Percent Insiders 41.3 | Percent Institutions 0.37 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
China Jo-Jo Drugstores Inc
Company Overview
History and Background
China Jo-Jo Drugstores Inc., founded in 2003, operates as a retailer and distributor of pharmaceutical products, nutritional supplements, and other healthcare products in China. It has expanded through acquisitions and organic growth, adapting to evolving market demands.
Core Business Areas
- Retail Pharmacy Operations: Operates a chain of retail pharmacies selling prescription and over-the-counter drugs, traditional Chinese medicine, nutritional supplements, personal care products, and medical devices.
- Wholesale and Distribution: Distributes pharmaceutical products and healthcare-related items to other pharmacies, hospitals, and retailers.
- Online Sales: Sells products through online platforms to reach a wider customer base.
Leadership and Structure
The company is led by a board of directors and an executive management team. The organizational structure typically includes departments for retail operations, wholesale distribution, marketing, finance, and administration.
Top Products and Market Share
Key Offerings
- Prescription Drugs: Prescription medications dispensed through its pharmacies. Market share data is not readily available. Competitors include other pharmacy chains and hospitals in China.
- Over-the-Counter (OTC) Drugs: A range of OTC medications for common ailments. Market share data is not readily available. Competitors include other pharmacy chains and supermarkets.
- Nutritional Supplements: Vitamins, minerals, and other health supplements. Market share data is not readily available. Competitors include other pharmacy chains and health stores.
Market Dynamics
Industry Overview
The Chinese pharmaceutical retail market is large and growing, driven by an aging population, increasing healthcare awareness, and rising disposable incomes. It's a competitive market with domestic and international players.
Positioning
China Jo-Jo Drugstores aims to be a trusted provider of healthcare products and services, leveraging its retail network and distribution capabilities. Its competitive advantages may include its local market knowledge and relationships with suppliers.
Total Addressable Market (TAM)
The Chinese pharmaceutical retail market is estimated to be worth hundreds of billions of USD. China Jo-Jo Drugstores holds a small percentage of the total market, with potential for expansion through strategic initiatives.
Upturn SWOT Analysis
Strengths
- Established retail network in certain regions of China
- Distribution capabilities
- Brand recognition (potentially regional)
- Experience in the Chinese pharmaceutical market
Weaknesses
- Limited geographic reach compared to larger competitors
- Reliance on suppliers for product sourcing
- Potential regulatory risks in China
- Smaller market capitalization
Opportunities
- Expanding into new geographic regions in China
- Increasing online sales
- Acquiring smaller pharmacy chains
- Offering new healthcare services in its pharmacies
Threats
- Intense competition from larger pharmacy chains
- Changing government regulations regarding drug pricing and distribution
- Counterfeit products
- Economic slowdown in China
Competitors and Market Share
Key Competitors
- LBPS
- PED
- SFUN
Competitive Landscape
China Jo-Jo Drugstores Inc. faces intense competition. Its advantage lies in its established network, while its disadvantage is its smaller size compared to larger players. Local market knowledge is an advantage, while brand recognition limitations are a disadvantage.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be determined due to the lack of publicly available recent and consistent data.
Future Projections: Future projections for China Jo-Jo Drugstores Inc's future growth based on analyst estimates cannot be provided due to the lack of coverage and readily available information.
Recent Initiatives: Recent strategic initiatives undertaken by China Jo-Jo Drugstores Inc cannot be provided due to the lack of publicly available recent and consistent data.
Summary
China Jo-Jo Drugstores Inc. is a small player in a large and competitive market. Its established retail network in certain Chinese regions is a strength, but limited geographic reach and competitive pressures present challenges. While a lack of data makes financial assessment difficult, expanding online and strategic acquisitions could improve its position.
Similar Companies
- LBPS
- PED
- SFUN
Sources and Disclaimers
Data Sources:
- Company website, SEC filings (where available), Market research reports (where available), General news sources.
Disclaimers:
The information provided is based on publicly available data and may not be entirely accurate or up-to-date. The analysis is for informational purposes only and should not be considered financial advice. Market share and financial data are estimates based on limited data.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About China Jo-Jo Drugstores Inc
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2008-05-16 | Chairman & CEO Mr. Lei Liu M.D. | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 939 | Website https://www.jiuzhou360.com |
Full time employees 939 | Website https://www.jiuzhou360.com |
China Jo-Jo Drugstores, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company offers consultation, examination, and treatment of common ailments by licensed doctors in western medicine and TCM at scheduled hours. In addition, it provides treatment for minor ailments, such as sprains, minor lacerations, and dizziness; acupuncture, therapeutic massage, and cupping services; and minor outpatient surgical treatments, including suturing. Further, it offers OTC drugs and nutritional supplements through its website www.dada360.com, as well as sells products through third-party platforms. Additionally, the company distributes third-party pharmaceutical products to trading companies, as well as cultivates and wholesales herbs used for TCM. It operates pharmacies under the Jiuzhou Grand Pharmacy name. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.